Episodes
Luminous: What Can Psychedelics Teach Us About Dying?
In the first episode in our series about psychedelics, how can psilocybin ease our fears about dying and help us make peace with the end of our lives? More
Luminous: Building The Psychedelic Revolution
In this episode of “Luminous,” we go inside Usona Institute’s chemistry lab and go deep with co-founder Bill Linton about what brought him to this unique moment in the psychedelic revolution. More
Luminous: Melissa Etheridge on Ayahuasca
The rock icon explains why she’s fascinated by psychedelics as a promising treatment for addiction, a path for spiritual exploration, and a source of creativity. More
Luminous: Your Brain on Shrooms
Can neuroscience explain what happens to the brain on psychedelics? And even if we map the brain while it’s tripping, does that tell us why these experiences can be so transformative? More
Luminous: What happens to an octopus on MDMA?
Gul Dolen is a pioneering neuroscientist who’s investigating the “critical periods” of psychedelics, including studies where she’s given MDMA — also known as “Molly” — to octopuses. More
Luminous: Can psychedelics be decolonized?
The knowledge about many psychedelics comes from Indigenous cultures — which raises ethical questions for the Western scientists studying them. Can psychedelics be decolonized? More
Luminous: Can you have too much transcendence?
Over the course of 20 years, Chris Bache had 73 high-dose LSD experiences — doses so high that the human body couldn’t tolerate anything more. More
Luminous: Is it the drug or is it the trip?
There’s a fascinating question at the heart of psychedelic science. Is it the mind-blowing experience that fundamentally changes a person’s outlook on life? Or is it the powerful molecules that rewire the brain? More
Luminous: A brief history of getting high
British historian Mike Jay wants to challenge the narrative of psychedelic “exceptionalism.” He also believes more scientists should talk about their personal psychedelic experiences. More